147 related articles for article (PubMed ID: 26849778)
1. Thiazolino 2-Pyridone Amide Inhibitors of Chlamydia trachomatis Infectivity.
Good JA; Silver J; Núñez-Otero C; Bahnan W; Krishnan KS; Salin O; Engström P; Svensson R; Artursson P; Gylfe Å; Bergström S; Almqvist F
J Med Chem; 2016 Mar; 59(5):2094-108. PubMed ID: 26849778
[TBL] [Abstract][Full Text] [Related]
2. Thiazolino 2-Pyridone Amide Isosteres As Inhibitors of Chlamydia trachomatis Infectivity.
Good JAD; Kulén M; Silver J; Krishnan KS; Bahnan W; Núñez-Otero C; Nilsson I; Wede E; de Groot E; Gylfe Å; Bergström S; Almqvist F
J Med Chem; 2017 Nov; 60(22):9393-9399. PubMed ID: 29053275
[TBL] [Abstract][Full Text] [Related]
3. Optimization of peptide-based inhibitors targeting the HtrA serine protease in Chlamydia: Design, synthesis and biological evaluation of pyridone-based and N-Capping group-modified analogues.
Hwang J; Strange N; Phillips MJA; Krause AL; Heywood A; Gamble AB; Huston WM; Tyndall JDA
Eur J Med Chem; 2021 Nov; 224():113692. PubMed ID: 34265463
[TBL] [Abstract][Full Text] [Related]
4. A series of ceramide analogs modified at the 1-position with potent activity against the intracellular growth of Chlamydia trachomatis.
Saied EM; Banhart S; Bürkle SE; Heuer D; Arenz C
Future Med Chem; 2015; 7(15):1971-80. PubMed ID: 26496536
[TBL] [Abstract][Full Text] [Related]
5. A 2-pyridone-amide inhibitor targets the glucose metabolism pathway of Chlamydia trachomatis.
Engström P; Krishnan KS; Ngyuen BD; Chorell E; Normark J; Silver J; Bastidas RJ; Welch MD; Hultgren SJ; Wolf-Watz H; Valdivia RH; Almqvist F; Bergström S
mBio; 2014 Dec; 6(1):e02304-14. PubMed ID: 25550323
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of ultrasound and antibiotics against Chlamydia trachomatis-infected human epithelial cells in vitro.
Ikeda-Dantsuji Y; Feril LB; Tachibana K; Ogawa K; Endo H; Harada Y; Suzuki R; Maruyama K
Ultrason Sonochem; 2011 Jan; 18(1):425-30. PubMed ID: 20728399
[TBL] [Abstract][Full Text] [Related]
7. Natural product inspired library synthesis - Identification of 2,3-diarylbenzofuran and 2,3-dihydrobenzofuran based inhibitors of Chlamydia trachomatis.
Saleeb M; Mojica S; Eriksson AU; Andersson CD; Gylfe Å; Elofsson M
Eur J Med Chem; 2018 Jan; 143():1077-1089. PubMed ID: 29232584
[TBL] [Abstract][Full Text] [Related]
8. A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis.
Muschiol S; Bailey L; Gylfe A; Sundin C; Hultenby K; Bergström S; Elofsson M; Wolf-Watz H; Normark S; Henriques-Normark B
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14566-71. PubMed ID: 16973741
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 3-isoxazolidone derivatives as new Chlamydia trachomatis inhibitors.
Abdelsayed S; Ha Duong NT; Hai J; Hémadi M; El Hage Chahine JM; Verbeke P; Serradji N
Bioorg Med Chem Lett; 2014 Aug; 24(16):3854-60. PubMed ID: 25027937
[TBL] [Abstract][Full Text] [Related]
10. Phenylimidazole derivatives of 4-pyridone as dual inhibitors of bacterial enoyl-acyl carrier protein reductases FabI and FabK.
Kitagawa H; Ozawa T; Takahata S; Iida M; Saito J; Yamada M
J Med Chem; 2007 Sep; 50(19):4710-20. PubMed ID: 17713898
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of roxithromycin against Chlamydia trachomatis.
Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Chlamydia trachomatis Growth During the Last Decade: A Mini-Review.
Serradji N; Vu TH; Kim H; Panyam J; Verbeke P
Mini Rev Med Chem; 2018; 18(16):1363-1372. PubMed ID: 29692244
[TBL] [Abstract][Full Text] [Related]
13. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
Mpiga P; Ravaoarinoro M
Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
[TBL] [Abstract][Full Text] [Related]
14. High-Throughput Screening for Novel Inhibitors of Intracellular Pathogens, Including Chlamydia trachomatis.
Brown AC; Kushner NL
Methods Mol Biol; 2019; 2042():279-286. PubMed ID: 31385282
[TBL] [Abstract][Full Text] [Related]
15. High dynamic range detection of Chlamydia trachomatis growth by direct quantitative PCR of the infected cells.
Eszik I; Lantos I; Önder K; Somogyvári F; Burián K; Endrész V; Virok DP
J Microbiol Methods; 2016 Jan; 120():15-22. PubMed ID: 26578244
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.
Wang SA; Papp JR; Stamm WE; Peeling RW; Martin DH; Holmes KK
J Infect Dis; 2005 Mar; 191(6):917-23. PubMed ID: 15717267
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Resistance Screening in Chlamydia trachomatis by Optimized McCoy Cell Culture System and Direct qPCR-Based Monitoring of Chlamydial Growth.
Meštrović T; Virok DP; Ljubin-Sternak S; Raffai T; Burián K; Vraneš J
Methods Mol Biol; 2019; 2042():33-43. PubMed ID: 31385269
[TBL] [Abstract][Full Text] [Related]
18. Improved plaque assay identifies a novel anti-Chlamydia ceramide derivative with altered intracellular localization.
Banhart S; Saied EM; Martini A; Koch S; Aeberhard L; Madela K; Arenz C; Heuer D
Antimicrob Agents Chemother; 2014 Sep; 58(9):5537-46. PubMed ID: 25001308
[TBL] [Abstract][Full Text] [Related]
19. Activity of Novispirin G-10, a novel antimicrobial peptide against Chlamydia trachomatis and vaginosis-associated bacteria.
Yasin B; Pang M; Lehrer RI; Wagar EA
Exp Mol Pathol; 2003 Apr; 74(2):190-5. PubMed ID: 12710952
[TBL] [Abstract][Full Text] [Related]
20. Assessing a potential role of host Pannexin 1 during Chlamydia trachomatis infection.
McKuen MJ; Dahl G; Fields KA
PLoS One; 2013; 8(5):e63732. PubMed ID: 23700432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
